The statistical analysis performed on the frontal lobe of control and AD cases showed a significantly increased number of S100A10 immunopositive ASLCs in the upper and lower frontal cortex and white matter of AD cases compared to controls (Figure 6). Here, S100A10 is linked to Alzheimer disease.